
    
      The purpose of this study is to the evaluate the use of a mobile and PSTN phone-based
      telehealth platform will be able to produce a reduction in the combined end point of all
      cause mortality, will have positive or negative impact in their generic and disease specific
      quality of life , or their specific activity compared with usual care. Following this; it is
      also hypothesized that this will also lead to a change in overall risk for CHF complications.
      In addition the patients' satisfaction using the telemedicine service will be studied. A
      Cost-Effective Analysis and Cost Utility Analysis will evaluate the tele-health service
      compared with the usual care from the health and social perspective.
    
  